Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes

Cytokine and Growth Factor Reviews

Volumn 24, Issue 5, 2013, Pages 427-431

  Lim, Key Hwan ^a   Ramakrishna, Suresh ^a   Baek, Kwang Hyun ^a  

^a Bundang CHA Hospital   (South Korea)

Author keywords

Cytokine inducible; Deubiquitination; Leukemia; Ubiquitin; Ubiquitination

Indexed keywords

ANTINEOPLASTIC AGENT; CYSTEINE PROTEINASE; DEUBIQUITINATING ENZYME 1; DEUBIQUITINATING ENZYME 2; DEUBIQUITINATING ENZYME 3; ENZYME INHIBITOR; HBX 44108; P 5091; UNCLASSIFIED DRUG;

CONFORMATIONAL TRANSITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; IMMUNOPATHOLOGY; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

CYTOKINE-INDUCIBLE; DEUBIQUITINATION; LEUKEMIA; UBIQUITIN; UBIQUITINATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; HUMANS; IMMUNE SYSTEM DISEASES; INTERLEUKINS; LYMPHOCYTES; SIGNAL TRANSDUCTION; UBIQUITIN THIOLESTERASE;

EID: 84884706110     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.05.007     Document Type: Short Survey

References (41)

1. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., et al. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. Journal of Biological Chemistry 2007, 282:17375-17386.
2. Scheffner M., Nuber U., Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995, 373:81-83.
3. Sigismund S., Polo S., Di Fiore P.P. Signaling through monoubiquitination. Current Topics in Microbiology and Immunology 2004, 286:149-185.
4. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews 2002, 82:373-428.
5. Wang H., Matsuzawa A., Brown S.A., Zhou J., Guy C.S., Tseng P.H., et al. Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:20197-20202.
6. Sun F., Kanthasamy A., Anantharam V., Kanthasamy A.G. Mitochondrial accumulation of polyubiquitinated proteins and differential regulation of apoptosis by polyubiquitination sites Lys-48 and -63. Journal of Cellular and Molecular Medicine 2009, 13:1632-1643.
7. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123:773-786.
8. Zhu Y., Carroll M., Papa F.R., Hochstrasser M., D'Andrea A.D. DUB-1, a deubiquitinating enzyme with growth-suppressing activity. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:3275-3279.
9. Baek K.H. Cytokine-regulated protein degradation by the ubiquitination system. Current Protein & Peptide Science 2006, 7:171-177.
10. Lee H.J., Kim M.S., Kim Y.K., Oh Y.K., Baek K.H. HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized. FEBS Letters 2005, 579:4867-4872.
11. Zhu Y., Pless M., Inhorn R., Mathey-Prevot B., D'Andrea A.D. The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. Molecular and Cellular Biology 1996, 16:4808-4817.
12. Rane S.G., Reddy E.P. JAKs, STATs and Src kinases in hematopoiesis. Oncogene 2002, 21:3334-3358.
13. Jaster R., Zhu Y., Pless M., Bhattacharya S., Mathey-Prevot B., D'Andrea A.D. JAK2 is required for induction of the murine DUB-1 gene. Molecular and Cellular Biology 1997, 17:3364-3372.
14. Baek K.H., Kim M.S., Kim Y.S., Shin J.M., Choi H.K. DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. Journal of Biological Chemistry 2004, 279:2368-2376.
15. Lee M.Y., Ajjappala B.S., Kim M.S., Oh Y.K., Baek K.H. DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. Journal of Cellular Biochemistry 2008, 105:1420-1429.
16. Hashimoto-Tane A., Yokosuka T., Sakata-Sogawa K., Sakuma M., Ishihara C., Tokunaga M., et al. Dynein-driven transport of T cell receptor microclusters regulates immune synapse formation and T cell activation. Immunity 2011, 34:919-931.
17. Schnyder T., Castello A., Feest C., Harwood N.E., Oellerich T., Urlaub H., et al. B cell receptor-mediated antigen gathering requires ubiquitin ligase Cbl and adaptors Grb2 and Dok-3 to recruit dynein to the signaling microcluster. Immunity 2011, 34:905-918.
18. Zhu Y., Lambert K., Corless C., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. Journal of Biological Chemistry 1997, 272:51-57.
19. Migone T.S., Humbert M., Rascle A., Sanden D., D'Andrea A., Johnston J.A. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal. Blood 2001, 98:1935-1941.
20. Baek K.H., Mondoux M.A., Jaster R., Fire-Levin E., D'Andrea A.D. DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. Blood 2001, 98:636-642.
21. Meenhuis A., Verwijmeren C., Roovers O., Touw I.P. The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor. Biochemical Journal 2011, 434:343-351.
22. Baek K.H., Lee H., Yang S., Lim S.B., Lee W., Lee J.E., et al. Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. PLoS ONE 2012, 7:e44223.
23. Burrows J.F., Kelvin A.A., McFarlane C., Burden R.E., McGrattan M.J., De la Vega M., et al. USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. Journal of Biological Chemistry 2009, 284:9587-9595.
24. Burrows J.F., McGrattan M.J., Johnston J.A. The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. Genomics 2005, 85:524-529.
25. Burrows J.F., McGrattan M.J., Rascle A., Humbert M., Baek K.H., Johnston J.A. DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. Journal of Biological Chemistry 2004, 279:13993-14000.
26. Ramakrishna S., Suresh B., Lee E.J., Lee H.J., Ahn W.S., Baek K.H. K63 specific deubiquitination of SDS3 by USP17 regulates HDAC activity. Journal of Biological Chemistry 2011, 286:10505-10514.
27. Shin J.M., Yoo K.J., Kim M.S., Kim D., Baek K.H. Hyaluronan-and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability. BMC Genomics 2006, 7:292.
28. Burrows J.F., Scott C.J., Johnston J.A. The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. BMC Genomics 2010, 11:250.
29. de la Vega M., Burrows J.F., McFarlane C., Govender U., Scott C.J., Johnston J.A. The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected. Journal of Biological Chemistry 2010, 285:12028-12036.
30. McFarlane C., Kelvin A.A., de la Vega M., Govender U., Scott C.J., Burrows J.F., et al. The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. Cancer Research 2010, 70:3329-3339.
31. Pereg Y., Liu B.Y., O'Rourke K.M., Sagolla M., Dey A., Komuves L., et al. Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nature Cell Biology 2010, 12:400-406.
32. Ramakrishna S., Suresh B., Bae S.M., Ahn W.S., Lim K.H., Baek K.H. Hyaluronan binding motifs of USP17 and SDS3 exhibit anti-tumor activity. PLoS ONE 2012, 7:e37772.
33. Chen R., Zhang L., Zhong B., Tan B., Liu Y., Shu H.B. The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. Cell Research 2010, 20:802-811.
34. de la Vega M., Kelvin A.A., Dunican D.J., McFarlane C., Burrows J.F., Jaworski J., et al. The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. Nature Communications 2011, 2:259.
35. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B., et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Molecular and Cellular Biology 1998, 18:4872-4882.
36. Naramura M., Kole H.K., Hu R.J., Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:15547-15552.
37. Reiley W.W., Zhang M., Jin W., Losiewicz M., Donohue K.B., Norbury C.C., et al. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nature Immunology 2006, 7:411-417.
38. Kapuria V., Peterson L.F., Fang D., Bornmann W.G., Talpaz M., Donato N.J. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cancer Research 2010, 70:9265-9276.
39. Colland F., Formstecher E., Jacq X., Reverdy C., Planquette C., Conrath S., et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Molecular Cancer Therapeutics 2009, 8:2286-2295.
40. Chauhan D., Tian Z., Nicholson B., Kumar K.G., Zhou B., Carrasco R., et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 2012, 22:345-358.
41. Kon N., Kobayashi Y., Li M., Brooks C.L., Ludwig T., Gu W. Inactivation of HAUSP in vivo modulates p53 function. Oncogene 2010, 29:1270-1279.